MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi 
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D....
The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome
Dravet syndrome is a rare, debilitating and difficult-to-treat lifelong epilepsy that begins in infancyEC approval is based on Phase 3...
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer
Equillium Further Strengthens Management Team with Additional Executive HiresLA JOLLA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq:...
TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline...
In Addition to Addressing COVID Vaccine Shipping and Storage Requirements, Reflect Scientific’s Proprietary Liquid Nitrogen-based Freezers are Continuing to Support Growing Cell and Gene Therapy Market Requirements for Ultra-Low Temperature Processing and Storage
OREM, Utah, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), is a provider of diverse products and...
Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
Trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such...
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
Company affirms plans to begin enrollment of patients with HR+ HER2- metastatic breast cancer and other tumors in U.S. Phase...
Viemed Healthcare Announces Entry into Remote Patient Monitoring Sector
LAFAYETTE, La., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a...
Keros Therapeutics Announces Addition to NASDAQ Biotechnology Index
LEXINGTON, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Aileron Therapeutics Provides Business Update and Outlines 2021 Strategic Priorities
Aileron’s 2021 strategic priorities aim to advance its vision to bring chemoprotection to all patients with p53-mutant cancers regardless of...
Recce Pharmaceuticals Provides Business Update
SYDNEY, Australia, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE), the Company developing new classes of synthetic...
Jushi Holdings Inc.’s BEYOND / HELLO to Open Its Second Retail Location in Sauget, Illinois, Its 13th Dispensary Nationally and Third in the State
Jushi Holdings Inc.’s BEYOND / HELLO to Open Its Second Retail Location in Sauget, Illinois, Its 13th Dispensary Nationally and...
Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast
VANCOUVER, British Columbia, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
DENVER, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging...
Jushi Holdings Inc. Provides Update on Acceleration of Warrants Expiry Date
Acceleration of warrants results in approximately USD$32 million in gross proceeds to the CompanyBOCA RATON, Fla., Dec. 21, 2020 (GLOBE...
Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the Company...
Successful Completion of In-Vivo Head-to-Head Comparator Study of EscharEx versus a Commercial Enzymatic Debridement Agent
Data to be Published in a Peer-Reviewed Journal in First Half 2021YAVNE, Israel, Dec. 21, 2020 (GLOBE NEWSWIRE) -- MediWound...
Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to...
The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
PLEGRIDY is now approved in the European Union for intramuscular injection, offering individuals with relapsing multiple sclerosis (MS) a differentiated,...